CU Medical Systems, Inc. (KOSDAQ: 115480)
South Korea
· Delayed Price · Currency is KRW
657.00
-26.00 (-3.81%)
Nov 15, 2024, 9:00 AM KST
CU Medical Systems Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 31,666 | 41,050 | 59,540 | 51,576 | 66,577 | 50,749 | |
Market Cap Growth | -43.00% | -31.05% | 15.44% | -22.53% | 31.19% | 43.47% | |
Enterprise Value | 60,618 | 56,832 | 70,311 | 58,869 | 134,333 | 101,817 | |
Last Close Price | 658.00 | 853.00 | 1305.00 | 1145.00 | 2223.63 | 2438.53 | |
PE Ratio | - | - | 6.25 | - | - | - | |
PS Ratio | 0.81 | 0.98 | 1.27 | 1.46 | 2.35 | 1.82 | |
PB Ratio | 0.57 | 0.76 | 1.00 | 1.05 | 1.45 | 0.91 | |
P/TBV Ratio | 0.61 | 0.78 | 1.07 | 1.13 | 1.82 | 1.15 | |
P/FCF Ratio | - | 21.69 | - | - | 9.33 | - | |
P/OCF Ratio | 3.30 | 4.96 | 19.07 | 105.17 | 7.91 | - | |
EV/Sales Ratio | 1.54 | 1.36 | 1.50 | 1.66 | 4.74 | 3.65 | |
EV/EBITDA Ratio | 8.57 | 8.12 | 5.44 | 13.63 | - | 23.97 | |
EV/EBIT Ratio | 12.29 | 11.23 | 6.23 | 24.78 | - | 109.51 | |
EV/FCF Ratio | -6.24 | 30.03 | - | - | 18.83 | - | |
Debt / Equity Ratio | 0.67 | 0.44 | 0.33 | 0.30 | 0.58 | 1.11 | |
Debt / EBITDA Ratio | 5.30 | 3.39 | 1.53 | 3.45 | - | 14.52 | |
Debt / FCF Ratio | - | 12.52 | - | - | 3.73 | - | |
Asset Turnover | 0.40 | 0.48 | 0.58 | 0.46 | 0.27 | 0.24 | |
Inventory Turnover | 2.15 | 2.14 | 2.60 | 2.03 | 1.23 | 1.09 | |
Quick Ratio | 2.04 | 0.83 | 1.59 | 2.48 | 0.84 | 0.69 | |
Current Ratio | 2.75 | 1.21 | 2.69 | 2.99 | 1.37 | 1.13 | |
Return on Equity (ROE) | -11.05% | -14.34% | 17.57% | -29.80% | -40.90% | -6.45% | |
Return on Assets (ROA) | 3.16% | 3.63% | 8.75% | 1.92% | -5.26% | 0.50% | |
Return on Capital (ROIC) | 3.44% | 4.03% | 9.87% | 2.18% | -5.84% | 0.55% | |
Earnings Yield | -20.80% | -19.98% | 15.83% | -27.11% | -38.66% | -5.74% | |
FCF Yield | -30.67% | 4.61% | -14.22% | -9.10% | 10.71% | -11.71% | |
Buyback Yield / Dilution | -3.80% | -5.90% | -33.07% | -52.90% | -36.70% | -3.71% | |
Total Shareholder Return | -3.80% | -5.90% | -33.07% | -52.90% | -36.70% | -3.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.